BMS-Claude Agreement Signals AI Integration Shift in Pharma | Pharmaceutical Commerce
PushButton AI Team ·
BMS-Claude Agreement Signals AI Integration Shift in Pharma | Pharmaceutical Commerce
You bought the AI tool. Nobody used it. $200/month quietly cancelled three months later.
You're not alone — and you're not behind.
Bristol-Myers Squibb just signed an enterprise deal to deploy AI ac
You bought the AI tool. Nobody used it. $200/month quietly cancelled three months later.
You're not alone — and you're not behind.
Bristol-Myers Squibb just signed an enterprise deal to deploy AI across their entire organization. Workflows, field teams, customer engagement — all of it. A Fortune 500 pharma company is still figuring this out too.
Here's what that tells you: even the biggest companies aren't running on gut instinct with AI. They're starting with specific problems in specific functions. Not "AI everywhere." One workflow. One team. One measurable improvement.
That's the pattern worth copying. Not the tool. The approach.
Pick one repetitive task your team complains about every week — summarizing reports, drafting follow-up emails, pulling data into updates. One task. Test AI on that single thing for 30 days. Measure the time saved. That's your proof of concept without blowing a budget or touching anything that works.
No consultants. No overhaul. No six-month rollout.
Just one win that shows your team AI is useful — not threatening.
What's the one task in your business that eats the most time but adds the least value? Drop it below.
